<!DOCTYPE html>
<html>
<head>
    <title>全文阅读--XML全文阅读--中国知网</title>
    <link rel="icon" href="/kxreader/favicon.ico" />
    <link rel="shortcut Icon" href="/kxreader/favicon.ico" />
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
    <meta name="keywords" content="文献 XML KBASE CNKI 中国知网" />
    <meta name="description" content="XML文献检索" />
    <link href="/kxreader/Content/css/detail?v=NOOK-mvTMnxl11s6oPYV0boPXN3iP4N7Rc-A56nk4KI1" rel="stylesheet"/>

    <script type="text/javascript">
        var APPPATH = '/kxreader';
    </script>
</head>

<body>
    
<script type="text/javascript" src="//login.cnki.net/TopLogin/api/loginapi/get?type=top&amp;localCSS=&amp;returnurl=%2f%2fkns.cnki.net%2fKXReader%2fDetail%3fTIMESTAMP%3d637141659537451250%26DBCODE%3dCJFD%26TABLEName%3dCJFDLAST2019%26FileName%3dXXGK201902020%26RESULT%3d1%26SIGN%3dC3s3RPbe21z2wsr8R%252fCbIhrUWLs%253d"></script>

<div id="headerBox" class="header">
    <div class="topbar">
        <div class="textalign">
            <a href="/kxreader/Detail?dbcode=CJFD&amp;filename=XXGK201902020&amp;align=md">
                <i class="icon-cen active" title="居中对齐"></i>
            </a>
            <a href="/kxreader/Detail?dbcode=CJFD&amp;filename=XXGK201902020&amp;align=lt">
                <i class="icon-left " title="左对齐"></i>
            </a>
        </div>
        <h6 class="free-tip"><i class="icon"></i>HTML阅读开放试用阶段，欢迎体验！</h6>
    </div>
</div>

    



<div class="btn-link" style="display: none"><a target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=XXGK201902020&amp;v=MTExMDhIOWpNclk5SFpJUUtESDg0dlI0VDZqNTRPM3pxcUJ0R0ZyQ1VSN3FmWnVabUZ5am1WN3ZPUFRYTVpiRzQ=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">知网节</a></div>

    <div class="main">

        

    <div class="sidebar-a">
        <!--sidebar start-->
        <div class="sidenav">
            <div class="arrow"><span></span></div>
            <!--sidebar_list start-->
            <dl class="sidenav-list">
                    <dt class="tit">目录结构</dt>
                            <dd class="guide">
                                    <p><a href="#47" data-title="&lt;b&gt;1 资料与方法&lt;/b&gt; "><b>1 资料与方法</b></a><i></i></p>
                                                                    <ul class="contentbox">
                                                <li><a href="#48" data-title="1.1 一般资料">1.1 一般资料</a></li>
                                                <li><a href="#50" data-title="1.2 方法">1.2 方法</a></li>
                                                <li><a href="#55" data-title="1.3 观察指标">1.3 观察指标</a></li>
                                                <li><a href="#57" data-title="1.4 统计学方法">1.4 统计学方法</a></li>
                                    </ul>
                            </dd>
                            <dd class="guide">
                                    <p><a href="#60" data-title="&lt;b&gt;2 结 果&lt;/b&gt; "><b>2 结 果</b></a><i></i></p>
                                                                    <ul class="contentbox">
                                                <li><a href="#61" data-title="2.1 两组患者cTnI水平变化的比较">2.1 两组患者cTnI水平变化的比较</a></li>
                                                <li><a href="#64" data-title="2.2 两组患者CK-MB水平变化的比较">2.2 两组患者CK-MB水平变化的比较</a></li>
                                                <li><a href="#67" data-title="2.3 两组患者治疗前后BNP水平变化的比较">2.3 两组患者治疗前后BNP水平变化的比较</a></li>
                                                <li><a href="#71" data-title="2.4 两组患者治疗前后LVEF、LVFS、LVEDd、LVESd水平变化的比较">2.4 两组患者治疗前后LVEF、LVFS、LVEDd、LVESd水平变化的比较</a></li>
                                                <li><a href="#75" data-title="2.5 高ANTH组患者BNP水平变化与LVEF、LVFS的相关性分析">2.5 高ANTH组患者BNP水平变化与LVEF、LVFS的相关性分析</a></li>
                                    </ul>
                            </dd>
                            <dd class="guide">
                                    <p><a href="#78" data-title="&lt;b&gt;3 讨 论&lt;/b&gt; "><b>3 讨 论</b></a><i></i></p>
                                                            </dd>
                            <dd class="guide">
                                    <p><a href="#" data-title="文内图表 ">文内图表</a><i></i></p>
                                                                    <ul class="contentbox">
                                                <li><a href="#63" data-title="&lt;b&gt;表&lt;/b&gt;1 &lt;b&gt;两组患者心肌肌钙蛋白&lt;/b&gt;I&lt;b&gt;水平比较&lt;/b&gt;"><b>表</b>1 <b>两组患者心肌肌钙蛋白</b>I<b>水平比较</b></a></li>
                                                <li><a href="#66" data-title="&lt;b&gt;表&lt;/b&gt;2 &lt;b&gt;两组患者肌酸激酶同工酶水平比较&lt;/b&gt;"><b>表</b>2 <b>两组患者肌酸激酶同工酶水平比较</b></a></li>
                                                <li><a href="#69" data-title="&lt;b&gt;表&lt;/b&gt;3 &lt;b&gt;两组患者治疗前后脑钠肽水平比较&lt;/b&gt;&lt;mathml id=&quot;70&quot;&gt;&lt;math xmlns=&quot;http://www.w3.org/1998/Math/MathML&quot;&gt;&lt;mrow&gt;&lt;mo stretchy=&quot;false&quot;&gt; (&lt;/mo&gt;&lt;mover accent=&quot;true&quot;&gt;&lt;mi&gt;X&lt;/mi&gt;&lt;mo&gt;&#175;&lt;/mo&gt;&lt;/mover&gt;&lt;mo&gt;&#177;&lt;/mo&gt;&lt;mi&gt;s&lt;/mi&gt;&lt;mo stretchy=&quot;false&quot;&gt;) &lt;/mo&gt;&lt;/mrow&gt;&lt;/math&gt;&lt;/mathml&gt;"><b>表</b>3 <b>两组患者治疗前后脑钠肽水平比较</b><mathml id="70"><math xmlns="http://www.w3.org/1998/Math/MathML"><mrow><mo stretchy="false"> (</mo><mover accent="true"><mi>X</mi><mo>¯</mo></mover><mo>±</mo><mi>s</mi><mo stretchy="false">) </mo></mrow></math></mathml></a></li>
                                                <li><a href="#73" data-title="&lt;b&gt;表&lt;/b&gt;4 &lt;b&gt;两组患者治疗前后左室射血分数等心脏指标水平比较&lt;/b&gt;&lt;mathml id=&quot;74&quot;&gt;&lt;math xmlns=&quot;http://www.w3.org/1998/Math/MathML&quot;&gt;&lt;mrow&gt;&lt;mo stretchy=&quot;false&quot;&gt; (&lt;/mo&gt;&lt;mover accent=&quot;true&quot;&gt;&lt;mi&gt;X&lt;/mi&gt;&lt;mo&gt;&#175;&lt;/mo&gt;&lt;/mover&gt;&lt;mo&gt;&#177;&lt;/mo&gt;&lt;mi&gt;s&lt;/mi&gt;&lt;mo stretchy=&quot;false&quot;&gt;) &lt;/mo&gt;&lt;/mrow&gt;&lt;/math&gt;&lt;/mathml&gt;"><b>表</b>4 <b>两组患者治疗前后左室射血分数等心脏指标水平比较</b><mathml id="74"><math xmlns="http://www.w3.org/1998/Math/MathML"><mrow><mo stretchy="false"> (</mo><mover accent="true"><mi>X</mi><mo>¯</mo></mover><mo>±</mo><mi>s</mi><mo stretchy="false">) </mo></mrow></math></mathml></a></li>
                                                <li><a href="#77" data-title="&lt;b&gt;图&lt;/b&gt;1 &lt;b&gt;高&lt;/b&gt;ANTH&lt;b&gt;组患者&lt;/b&gt;BNP&lt;b&gt;水平变化与&lt;/b&gt;LVEF、LVFS&lt;b&gt;的相关性分析&lt;/b&gt;"><b>图</b>1 <b>高</b>ANTH<b>组患者</b>BNP<b>水平变化与</b>LVEF、LVFS<b>的相关性分析</b></a></li>
                                    </ul>
                            </dd>
                                    <dd class="guide">
                                        <h6>
                                            <p><a href="#a_bibliography">参考文献</a> </p>
                                        </h6>
                                    </dd>

            </dl>
        </div>
        <!--sidebar end-->
        &nbsp;
        <!--此处有一空格符 勿删-->
    </div>

                <div class="sidebar-b three-collumn" style="width:0;">
            <div class="refer" style="width: 0;">
                <div class="arrow off" title="参考文献"><span></span></div>
                <div class="js-scrollbox" >
                    
                    <div class="subbox active">
                        <h4>
                            <span class="tit">参考文献</span>
                            <a class="close" href="javascript:void(0)">x</a>
                        </h4>
                        <div class="side-scroller">
                            <ul class="refer-list">
                                <li id="104">


                                    <a id="bibliography_1" title="杜天幸, 杨继元.蒽环类抗肿瘤药物对心脏毒性防治的研究进展[J].华南国防医学杂志, 2015, 29 (1) :80-82." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=HNGY201501033&amp;v=MzEyNzQ5R1o0UUtESDg0dlI0VDZqNTRPM3pxcUJ0R0ZyQ1VSN3FmWnVabUZ5am1WN3ZPTFNQTWQ3RzRIOVRNcm8=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[1]</b>
                                        杜天幸, 杨继元.蒽环类抗肿瘤药物对心脏毒性防治的研究进展[J].华南国防医学杂志, 2015, 29 (1) :80-82.
                                    </a>
                                </li>
                                <li id="106">


                                    <a id="bibliography_2" title="吴周贵, 李金国.超声心动图对蒽环类化疗药物心脏毒性的评价进展[J].医学综述, 2015, 21 (8) :1452-1454." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=YXZS201508044&amp;v=MjAzMDdUNmo1NE8zenFxQnRHRnJDVVI3cWZadVptRnlqbVY3dk9QRFhSZmJHNEg5VE1wNDlCWUlRS0RIODR2UjQ=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[2]</b>
                                        吴周贵, 李金国.超声心动图对蒽环类化疗药物心脏毒性的评价进展[J].医学综述, 2015, 21 (8) :1452-1454.
                                    </a>
                                </li>
                                <li id="108">


                                    <a id="bibliography_3" title="林莹, 李彦华, 郭新红, 等.蒽环类抗肿瘤药诱发心肌病1例及文献复习[J].中华老年多器官疾病杂志, 2017, 16 (1) :61-63." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=ZLQG201701018&amp;v=MjYyMDNVUjdxZlp1Wm1GeWptVjd2T1B5SGFhYkc0SDliTXJvOUViSVFLREg4NHZSNFQ2ajU0TzN6cXFCdEdGckM=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[3]</b>
                                        林莹, 李彦华, 郭新红, 等.蒽环类抗肿瘤药诱发心肌病1例及文献复习[J].中华老年多器官疾病杂志, 2017, 16 (1) :61-63.
                                    </a>
                                </li>
                                <li id="110">


                                    <a id="bibliography_4" title="赵越, 李怀业, 袁兰, 等.蒽环类化合物的结构修饰及抗肿瘤活性研究进展[J].中国药学杂志, 2016, 51 (12) :953-961." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=ZGYX201612001&amp;v=MDMzMDk5Zk5yWTlGWllRS0RIODR2UjRUNmo1NE8zenFxQnRHRnJDVVI3cWZadVptRnlqbVY3dk9QeXJTZHJHNEg=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[4]</b>
                                        赵越, 李怀业, 袁兰, 等.蒽环类化合物的结构修饰及抗肿瘤活性研究进展[J].中国药学杂志, 2016, 51 (12) :953-961.
                                    </a>
                                </li>
                                <li id="112">


                                    <a id="bibliography_5" title="王琳, 杨雪, 肖玲芳, 等.蒽环类药物心脏毒性分析及临床使用建议[J].中国现代医学杂志, 2017, 27 (12) :101-105." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=ZXDY201712021&amp;v=MDIyMTZWN3ZPUHpYUGQ3RzRIOWJOclk5SFpZUUtESDg0dlI0VDZqNTRPM3pxcUJ0R0ZyQ1VSN3FmWnVabUZ5am0=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[5]</b>
                                        王琳, 杨雪, 肖玲芳, 等.蒽环类药物心脏毒性分析及临床使用建议[J].中国现代医学杂志, 2017, 27 (12) :101-105.
                                    </a>
                                </li>
                                <li id="114">


                                    <a id="bibliography_6" title="胡慧敏, 张伟令, 黄东生, 等.儿童蒽环类药物心脏毒性研究进展[J].国际儿科学杂志, 2016, 43 (1) :1-4." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=GEKX201601003&amp;v=Mjg2MjRkckc0SDlmTXJvOUZaNFFLREg4NHZSNFQ2ajU0TzN6cXFCdEdGckNVUjdxZlp1Wm1GeWptVjd2T0lpakE=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[6]</b>
                                        胡慧敏, 张伟令, 黄东生, 等.儿童蒽环类药物心脏毒性研究进展[J].国际儿科学杂志, 2016, 43 (1) :1-4.
                                    </a>
                                </li>
                                <li id="116">


                                    <a id="bibliography_7" title="张楚婕, 程蕾蕾.蒽环类药物致心脏毒性的预防与治疗现状[J].中国临床医学, 2016, 23 (1) :110-113." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=LCYX201601033&amp;v=Mjg5OTBmTXJvOUdaNFFLREg4NHZSNFQ2ajU0TzN6cXFCdEdGckNVUjdxZlp1Wm1GeWptVjd2T0tTN1Nkckc0SDk=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[7]</b>
                                        张楚婕, 程蕾蕾.蒽环类药物致心脏毒性的预防与治疗现状[J].中国临床医学, 2016, 23 (1) :110-113.
                                    </a>
                                </li>
                                <li id="118">


                                    <a id="bibliography_8" title="慕万颖, 刘伶.蒽环类药物治疗儿童白血病致心脏损害的评价及对策[J].医学综述, 2016, 22 (6) :1145-1148." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=YXZS201606032&amp;v=MTM5MzlLREg4NHZSNFQ2ajU0TzN6cXFCdEdGckNVUjdxZlp1Wm1GeWptVjd2T1BEWFJmYkc0SDlmTXFZOUdab1E=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[8]</b>
                                        慕万颖, 刘伶.蒽环类药物治疗儿童白血病致心脏损害的评价及对策[J].医学综述, 2016, 22 (6) :1145-1148.
                                    </a>
                                </li>
                                <li id="120">


                                    <a id="bibliography_9" title="金之湲, 胡燕华.超声心动图评估蒽环类化疗药物心脏毒性的临床研究进展[J].内蒙古医科大学学报, 2016, 38 (3) :255-258." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=NMYX201603016&amp;v=MzI3MTFNckk5RVlvUUtESDg0dlI0VDZqNTRPM3pxcUJ0R0ZyQ1VSN3FmWnVabUZ5am1WN3ZPS3lEU2RyRzRIOWY=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[9]</b>
                                        金之湲, 胡燕华.超声心动图评估蒽环类化疗药物心脏毒性的临床研究进展[J].内蒙古医科大学学报, 2016, 38 (3) :255-258.
                                    </a>
                                </li>
                                <li id="122">


                                    <a id="bibliography_10" title="Mele D, Nardozza M, Spallarossa P, et al.Current views on anthracycline cardiotoxicity[J].Heart Fail Rev, 2016, 21 (5) :621-634." target="_blank"
                                       href="http://scholar.cnki.net/result.aspx?q=Current views on anthracycline cardiotoxicity">
                                        <b>[10]</b>
                                        Mele D, Nardozza M, Spallarossa P, et al.Current views on anthracycline cardiotoxicity[J].Heart Fail Rev, 2016, 21 (5) :621-634.
                                    </a>
                                </li>
                                <li id="124">


                                    <a id="bibliography_11" title="Cardinale D, Colombo A, Bacchiani G, et al.Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy[J].Circulation, 2015, 131 (22) :1981-1988." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=SJWK&amp;filename=SJWK15060400000041&amp;v=MTQ0OTVNcTQ5RlpPc1BESGc0b0JNVDZUNFBRSC9pclJkR2VycVFUTW53WmVadEZpbmxVcmZJSUYwUWJoUT1OaWZjWmJLOUh0Zg==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[11]</b>
                                        Cardinale D, Colombo A, Bacchiani G, et al.Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy[J].Circulation, 2015, 131 (22) :1981-1988.
                                    </a>
                                </li>
                                <li id="126">


                                    <a id="bibliography_12" title="罗霞, 程黎明.抗癌药物引起心脏毒性的生物标志物研究进展[J].内科急危重症杂志, 2017, 23 (1) :65-69." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=NKJW201701023&amp;v=Mjg4MTJybzlIWjRRS0RIODR2UjRUNmo1NE8zenFxQnRHRnJDVVI3cWZadVptRnlqbVY3dk9LeWJCZWJHNEg5Yk0=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[12]</b>
                                        罗霞, 程黎明.抗癌药物引起心脏毒性的生物标志物研究进展[J].内科急危重症杂志, 2017, 23 (1) :65-69.
                                    </a>
                                </li>
                                <li id="128">


                                    <a id="bibliography_13" title="姚亮, 张晓娟, 田富国.小剂量卡维地洛联合坎地沙坦与右丙亚胺对接受蒽环类药物化疗乳腺癌患者的心脏保护作用的对比研究[J].中国药物与临床, 2016, 16 (11) :1634-1637." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=YWLC201611039&amp;v=MzI0MDRiYkc0SDlmTnJvOUdiWVFLREg4NHZSNFQ2ajU0TzN6cXFCdEdGckNVUjdxZlp1Wm1GeWptVjd2T1BEckg=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[13]</b>
                                        姚亮, 张晓娟, 田富国.小剂量卡维地洛联合坎地沙坦与右丙亚胺对接受蒽环类药物化疗乳腺癌患者的心脏保护作用的对比研究[J].中国药物与临床, 2016, 16 (11) :1634-1637.
                                    </a>
                                </li>
                                <li id="130">


                                    <a id="bibliography_14" title="Adamcova M, Lencova Popelova O, Jirkovsky E, et al.Experimental determination of diagnostic window of cardiac troponins in the development of chronic anthracycline cardiotoxicity and estimation of its predictive value[J].Int J Cardiol, 2015, 201 (2) :358-367." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=SJES&amp;filename=SJES15122500348534&amp;v=MjM0MjI0UFFIL2lyUmRHZXJxUVRNbndaZVp0RmlubFVyZklJRjBRYmhRPU5pZk9mYks5SDlQT3FvOUZaKzhIQ1g4OW9CTVQ2VA==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[14]</b>
                                        Adamcova M, Lencova Popelova O, Jirkovsky E, et al.Experimental determination of diagnostic window of cardiac troponins in the development of chronic anthracycline cardiotoxicity and estimation of its predictive value[J].Int J Cardiol, 2015, 201 (2) :358-367.
                                    </a>
                                </li>
                                <li id="132">


                                    <a id="bibliography_15" title="覃业语, 苏素文.抗肿瘤药物心脏毒性作用机制研究进展[J].海南医学, 2015, 26 (24) :3661-3664." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=HAIN201524022&amp;v=MzAzMTZab1FLREg4NHZSNFQ2ajU0TzN6cXFCdEdGckNVUjdxZlp1Wm1GeWptVjd2T0xTekNZTEc0SDlUT3E0OUg=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[15]</b>
                                        覃业语, 苏素文.抗肿瘤药物心脏毒性作用机制研究进展[J].海南医学, 2015, 26 (24) :3661-3664.
                                    </a>
                                </li>
                                <li id="134">


                                    <a id="bibliography_16" title="汪羚利, 陈少敏, 李昭屏.超声心动图评价抗肿瘤药物心脏毒性的研究进展[J].心血管病学进展, 2016, 37 (5) :516-521." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=XXGB201605016&amp;v=MzE4OTJPM3pxcUJ0R0ZyQ1VSN3FmWnVabUZ5am1WN3ZPUFRYTWJMRzRIOWZNcW85RVlvUUtESDg0dlI0VDZqNTQ=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[16]</b>
                                        汪羚利, 陈少敏, 李昭屏.超声心动图评价抗肿瘤药物心脏毒性的研究进展[J].心血管病学进展, 2016, 37 (5) :516-521.
                                    </a>
                                </li>
                                <li id="136">


                                    <a id="bibliography_17" title="Jirkovsk&#225;-V&#225;vrov&#225; A, Roh &#225; O, et al.Synthesis and analysis of novel analogues of dexrazoxane and its open-ring hydrolysis product for protection against anthracycline cardiotoxicity in vitro and in vivo[J].Toxicol Res, 2015, 4 (4) :1098-1114." target="_blank"
                                       href="http://scholar.cnki.net/result.aspx?q=Synthesis and analysis of novel analogues of dexrazoxane and its open-ring hydrolysis product for protection against anthracycline cardiotoxicity in vitro and in vivo">
                                        <b>[17]</b>
                                        Jirkovsk&#225;-V&#225;vrov&#225; A, Roh &#225; O, et al.Synthesis and analysis of novel analogues of dexrazoxane and its open-ring hydrolysis product for protection against anthracycline cardiotoxicity in vitro and in vivo[J].Toxicol Res, 2015, 4 (4) :1098-1114.
                                    </a>
                                </li>
                                <li id="138">


                                    <a id="bibliography_18" title="卢少玲, 张烁.病毒性心肌炎演变为扩张型心肌病的机制[J].心血管康复医学杂志, 2016, 25 (3) :341-343." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=XXGK201603031&amp;v=MjQ5NTFtRnlqbVY3dk9QVFhNWmJHNEg5Zk1ySTlHWllRS0RIODR2UjRUNmo1NE8zenFxQnRHRnJDVVI3cWZadVo=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[18]</b>
                                        卢少玲, 张烁.病毒性心肌炎演变为扩张型心肌病的机制[J].心血管康复医学杂志, 2016, 25 (3) :341-343.
                                    </a>
                                </li>
                                <li id="140">


                                    <a id="bibliography_19" title="吴红, 韩薇.mTOR信号通路在心血管系统中作用研究的进展[J].心血管康复医学杂志, 2016, 25 (2) :225-228." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=XXGK201602035&amp;v=MDYxODc0SDlmTXJZOUdZWVFLREg4NHZSNFQ2ajU0TzN6cXFCdEdGckNVUjdxZlp1Wm1GeWptVjd2T1BUWE1aYkc=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[19]</b>
                                        吴红, 韩薇.mTOR信号通路在心血管系统中作用研究的进展[J].心血管康复医学杂志, 2016, 25 (2) :225-228.
                                    </a>
                                </li>
                                <li id="142">


                                    <a id="bibliography_20" title="Quyam S, Steeden J, Muthurangu V, et al.Characterisation of anthracycline cardiotoxicity in long-term childhood cancer survivors using conventional and novel CMR techniques:probing the pathology[J].J Cardiovasc Magn Reson, 2015, 17 (1) :1-3." target="_blank"
                                       href="http://scholar.cnki.net/result.aspx?q=Characterisation of anthracycline cardiotoxicity in long-term childhood cancer survivors using conventional and novel CMR techniques:probing the pathology">
                                        <b>[20]</b>
                                        Quyam S, Steeden J, Muthurangu V, et al.Characterisation of anthracycline cardiotoxicity in long-term childhood cancer survivors using conventional and novel CMR techniques:probing the pathology[J].J Cardiovasc Magn Reson, 2015, 17 (1) :1-3.
                                    </a>
                                </li>
                            </ul>
                            <div style='display: none;' class="zqscroller" >
                                <h4 class="">附加材料</h4>
                                <ul></ul>
                            </div>
                        </div>
                    </div>
                </div>
            </div>
            &nbsp;
            <!--此处有一空格符 勿删-->
        </div>

        
    <div class="content">



        <!--tips start-->
                            <div class="tips">
                    <a href="http://navi.cnki.net/KNavi/JournalDetail?pcode=CJFD&amp;pykm=XXGK" target="_blank">心血管康复医学杂志</a>
                2019,28(02),207-211 DOI:10.3969/j.issn.1008-0074.2019.02.20            </div>
        <!--tips end-->
            <div class="top-title">
                <h1 class="title">
                    <span class="vm"><b>蒽环类抗肿瘤药物的心脏毒性及其防治分析</b></span>
                                    </h1>

            </div>
                        <h2>
                                <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=au&amp;skey=%E5%BC%A0%E8%89%B3%E8%95%8A&amp;code=41672549&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">张艳蕊</a>
                </h2>
                    <h2>
                    <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=in&amp;skey=%E6%89%BF%E5%BE%B7%E5%B8%82%E4%B8%B0%E5%AE%81%E6%BB%A1%E6%97%8F%E8%87%AA%E6%B2%BB%E5%8E%BF%E5%8C%BB%E9%99%A2%E5%86%85%E4%B8%89%E7%A7%91&amp;code=0154798&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">承德市丰宁满族自治县医院内三科</a>
            </h2>

        
<div class="link">
    <a id="aexport" class="icon icon-output"  onclick="" href="javascript:void(0);"><i></i>导出/参考文献</a>
    
    <span class="shareBoard" onmouseover="$('#sharedet').show();$('#this').addClass('shareBoardCUR')" onmouseout="$('#sharedet').hide();$('#this').removeClass('shareBoardCUR')">
        <a class="icon icon-share" href="#"><i></i>分享<em></em></a>
        <ul class="shareHide" id="sharedet" style="display: none;">
            <li><a title="复制链接" class="copy" onclick="" href="#"><i></i>复制链接</a></li>
            <li><a title="分享到新浪微博" class="xl" onclick="" href="javascript:common.ShareAction('xl');"><i></i>新浪微博</a></li>
            <li>
                <a title="分享到微信" class="wx" onclick="" href="#"><i></i>微信扫一扫</a>
                <div class="qrcode"><img src='' alt='' /></div>
            </li>
        </ul>

    </span>
    
    <a id="RefTrack" title="创建引文跟踪" class="icon icon-track" onclick="" href="javascript:void(0);"> <i></i>创建引文跟踪 </a>
    <a id="ashoucang" title="收藏" class="icon icon-favor" onclick="" href="javascript:void(0);"><i></i>收藏</a>
    <a class="icon icon-print" onclick="window.print();" href="javascript:void(0);"><i></i>打印</a>
    
    <!--版本切换 end-->
</div>
                            <div class="data" id="a_abstract">
                <span class="keys">摘<span style="font-family: 'Times New Roman';">&nbsp;&nbsp;&nbsp;&nbsp;</span>要：</span>
                <p><b>目的</b>:研究在肿瘤治疗中使用蒽环类药物的心脏毒性及其防治措施。<b>方法</b>:选择2014年1月-2015年1月在我院进行抗肿瘤治疗的患者160例作为研究对象。根据使用的蒽环类抗肿瘤药物累积量 (ANTH) , 患者被分为高ANTH组 (ANTH&gt;100mg/m<sup>2</sup>, 110例) 和低ANTH组 (ANTH≤100mg/m<sup>2</sup>, 50例) , 两组均治疗24个月。比较两组患者治疗前后的心肌肌钙蛋白I (cTnI) 、肌酐激酶同工酶 (CK-MB) 、脑钠肽 (BNP) 、左室射血分数 (LVEF) 、左室短轴缩短率 (LVFS) 、左室舒张末期内径 (LVEDd) 、左室收缩末期内径 (LVESd) 。<b>结果</b>:两组患者的cTnI和CK-MB水平的变化无显著差异, <i>P</i>均&gt;0.05。与低ANTH组相比, 高ANTH组治疗24个月后的BNP水平[ (41.2±15.1) ng/ml比 (46.9±15.2) ng/ml]、LVEDd [ (32.8±4.3) mm比 (34.6±4.6) mm]及LVESd[ (21.4±2.6) mm比 (22.7±3.4) mm]显著升高, 而LVEF[ (71.5±5.7) %比 (65.7±7.1) %]及LVFS[ (38.9±4.6) %比 (37.2±4.2) %]均显著降低, <i>P</i>&lt;0.05或&lt;0.01。治疗前后BNP水平与LVEF、LVFS不存在显著相关性 (<i>P</i>均&gt;0.05) 。<b>结论</b>:蒽环类抗肿瘤药物会引起患者心脏毒性的产生或发展, 使患者的BNP水平显著升高, LVEF水平显著降低, 因此, 应采取一定的防治措施减少其对患者心脏产生的不良影响。</p>
            </div>
                    <div class="data" id="a_keywords">
                <span class="keys">关键词：</span>
                <p>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=%E5%BF%83%E8%84%8F%E6%AF%92%E7%B4%A0%E7%B1%BB&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">心脏毒素类;</a>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=%E8%92%BD%E7%8E%AF%E7%B1%BB&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">蒽环类;</a>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=%E6%8A%97%E8%82%BF%E7%98%A4%E8%8D%AF&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">抗肿瘤药;</a>
                </p>
            </div>
        
        <!--brief start-->
        
            <div class="brief">
                    <p>
                                            </p>
                                    <p><b>收稿日期：</b>2017-12-02</p>

            </div>
                    <h1>Cardiac toxicity of anthracycline antineoplastic drugs and its prevention and treatment</h1>
                    <h2>
                    <span>ZHANG Yan-rui</span>
            </h2>
                    <h2>
                    <span>Third Department of Internal Medicine, Fengning Man Nationality Autonomous County Hospital, Chengde</span>
            </h2>
                            <div class="data" id="a_abstractEN">
                <span class="keys">Abstract：</span>
                <p><b>Objective</b>: To study cardiac toxicity of anthracycline antineoplastic drugs and its preventive and therapeutic measures. <b>Methods</b>:A total of 160 patients undergoing anti-tumor treatment in our hospital from Jan 2014 to Jan 2015 were enrolled. According to accumulated dose of anthracycline (ANTH) , patients were divided into high ANTH group (ANTH&gt;100 mg/m<sup>2</sup>, n=110) and low ANTH group (ANTH≤100 mg/m<sup>2</sup>, n=50) , both groups were treated for 24 months. Levels of cardiac troponin I (cTnI) , creatine kinase isoenzyme MB (CK-MB) , brain natriuretic peptide (BNP) , left ventricular ejection fraction (LVEF) , left ventricular fractional shortening (LVFS) , left ventricular end-diastolic diameter (LVEDd) and left ventricular end-systolic diameter (LVESd) were measured and compared between two groups before and after treatment. <b>Results</b>:There were no significant differences in levels of cTnI and CK-MB between the two groups, <i>P</i>&gt;0.05 both. Compared with low ANTH group after 24-month treatment, there were significant rise in BNP level [ (41.2±15.1) ng/ml vs. (46.9±15.2) ng/ml], LVEDd [ (32.8±4.3) mm vs. (34.6±4.6) mm] and LVESd [ (21.4±2.6) mm vs. (22.7±3.4) mm], and significant reductions in LVEF[ (71.5±5.7) % vs. (65.7±7.1) %] and LVFS [ (38.9±4.6) % vs. (37.2±4.2) %] in high ANTH group, <i>P</i>&lt;0.05 or &lt;0.01. There was no significant correlation among BNP level, LVEF and LVFS before and after treatment (<i>P</i>&gt;0.05 all) . <b>Conclusion</b>:Anthracycline antineoplastic drugs can induce cardiac toxicity or make it develop, so significantly increase BNP level and reduce LVEF in patients. Therefore, certain preventive measures should be performed to reduce its adverse effects on heart.</p>
            </div>
                    <div class="data" id="a_keywordsEN">
                <span class="keys">Keyword：</span>
                <p>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=Cardiotoxins&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">Cardiotoxins;</a>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=Anthracyclines&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">Anthracyclines;</a>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=Antineoplastic%20agents&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">Antineoplastic agents;</a>
                </p>
            </div>
                    <div class="brief">
                
                    <p>
                                            </p>
                                    <p><b>Received：</b> 2017-12-02</p>
                            </div>


        <!--brief start-->
                        <div class="p1">
                    <p id="46">据《美国国家癌症研究所杂志》的相关资料显示, 癌症患者在进行化疗后出现心血管疾病的人数呈明显的上升趋势<citation id="144" type="reference"><link href="104" rel="bibliography" /><sup>[<a class="sup">1</a>]</sup></citation>。随着近年来经济水平和医疗卫生水平的提高, 癌症存活患者的数量越来越多, 但其中也存在着较多的不良事件, 尤以心血管疾病为主<citation id="145" type="reference"><link href="106" rel="bibliography" /><sup>[<a class="sup">2</a>]</sup></citation>。心血管疾病可能会对患者的治疗效果产生影响, 所以在对患者进行抗肿瘤药物的使用中, 应对其对患者心脏毒性的影响进行探究<citation id="146" type="reference"><link href="108" rel="bibliography" /><sup>[<a class="sup">3</a>]</sup></citation>。本文为研究在对肿瘤的治疗中使用蒽环类药物对患者心脏毒性的影响及其防治措施, 选择了2014年1月～2015年1月在丰宁满族自治县医院进行抗肿瘤治疗的患者160例作为研究对象, 现作如下报道。</p>
                </div>
                <h3 id="47" name="47" class="anchor-tag"><b>1 资料与方法</b></h3>
                <h4 class="anchor-tag" id="48" name="48">1.1 一般资料</h4>
                <div class="p1">
                    <p id="49">选择2014年1月～2015年1月在丰宁满族自治县医院进行抗肿瘤治疗的患者160例, 纳入标准:经诊断, 确诊为癌症患者;治疗过程中存在蒽环类抗癌药物的使用;自愿签署知情同意书<citation id="147" type="reference"><link href="110" rel="bibliography" /><sup>[<a class="sup">4</a>]</sup></citation>。排除标准:患有高血压或存在高血压既往史;存在基础心脏病;存在肿瘤心脏侵犯或原发性心脏肿瘤;不愿配合本次治疗及研究者<citation id="148" type="reference"><link href="112" rel="bibliography" /><sup>[<a class="sup">5</a>]</sup></citation>。根据其使用的蒽环类抗肿瘤药物累积量 (ANTH) 进行分组, ANTH&gt;100mg/m<sup>2</sup>的患者110例为高ANTH组, ANTH≤100mg/m<sup>2</sup>的患者50例为低ANTH组。高ANTH组中男68例, 女42例;年龄43～67 (55.6±3.7) 岁。低ANTH组中男27例, 女23例;年龄42～66 (54.8±3.4) 岁。两组患者的年龄、性别等一般资料无显著差异 (<i>P</i>&gt;0.05) , 具有可比性。患者均知情同意本研究, 并经过医院伦理委员会批准。</p>
                </div>
                <h4 class="anchor-tag" id="50" name="50">1.2 方法</h4>
                <div class="p1">
                    <p id="51">对两组患者治疗前及治疗1周、1个月、2个月、3个月、6个月、9个月、12个月、15个月、18个月、21个月、24个月后的心肌肌钙蛋白I (cTnI) 、肌酸激酶同工酶 (CK-MB) 、脑钠肽 (BNP) 、心脏彩色多普勒超声左心射血分数 (LVEF) 、心电图等的动态变化进行监测, 以上述指标作为检验蒽环类抗癌药物对患者心脏毒性影响的标准。两组患者化疗方案均含有相关蒽环类药物, 包括表柔比星、多柔比星、去甲柔红霉素及柔红霉素, 但其累积量不得超过以下标准:表柔比星900mg/m<sup>2</sup>、多柔比星450mg/m<sup>2</sup>、去甲柔红霉素900mg/m<sup>2</sup>、柔红霉素900mg/m<sup>2</sup><citation id="149" type="reference"><link href="114" rel="bibliography" /><sup>[<a class="sup">6</a>]</sup></citation>。</p>
                </div>
                <div class="p1">
                    <p id="52">cTnI测定:将特异性cTnI单克隆体与化学发光反应相结合, 以此建立免疫化学发光测定法, 就是指通过抗cTnI单克隆体建立起双抗体夹心法, 中间载体为磁体微颗粒, 检测信号为化学发光<citation id="150" type="reference"><link href="116" rel="bibliography" /><sup>[<a class="sup">7</a>]</sup></citation>。</p>
                </div>
                <div class="p1">
                    <p id="53">CK-MB测定:通过免疫抑制法对CK-MB进行测定, 在这种方法下, CK-M单体抗体全部存在, 而标本的CK-MM和CK-MB的活性会受到一定程度的抑制, 其中CK-MB中的B亚基活性不会受到影响, 将所测得的CK-BB的活性翻倍, 则是标本中CK-MB的活性<citation id="151" type="reference"><link href="118" rel="bibliography" /><sup>[<a class="sup">8</a>]</sup></citation>。</p>
                </div>
                <div class="p1">
                    <p id="54">脑钠肽测定:通过化学发光法, 使用免疫发光分析仪 (德国Bayer Centaur) 对脑钠肽进行检测, 所用试剂为Bayer公司生产。</p>
                </div>
                <h4 class="anchor-tag" id="55" name="55">1.3 观察指标</h4>
                <div class="p1">
                    <p id="56">观察并记录两组患者cTnI及CK-MB的升高现象、治疗前后BNP的变化情况、治疗前后LVEF、左室缩短率 (LVFS) 、左室舒张末期内径 (LVEDd) 、左室收缩末期内径 (LVESd) 水平的变化。若出现以下现象:治疗后, 患者BNP水平升高;LVEF水平下降;cTnI及CK-MB出现升高现象;心电图发生变化;伴有典型的心脏损伤临床症状, 例如水肿、劳累性呼吸困难、颈静脉怒张等, 则判定患者出现心脏毒性损害。</p>
                </div>
                <h4 class="anchor-tag" id="57" name="57">1.4 统计学方法</h4>
                <div class="p1">
                    <p id="58">采用SPSS 18.0软件进行数据统计, 计量资料以均数±标准差<mathml id="59"><math xmlns="http://www.w3.org/1998/Math/MathML"><mrow><mo stretchy="false"> (</mo><mover accent="true"><mi>X</mi><mo>¯</mo></mover><mo>±</mo><mi>s</mi><mo stretchy="false">) </mo></mrow></math></mathml>表示, 比较采用<i>t</i>检验, 计数资料以百分率表示, 比较采用<i>χ</i><sup>2</sup>检验。<i>P</i>&lt;0.05为差异有统计学意义。</p>
                </div>
                <h3 id="60" name="60" class="anchor-tag"><b>2 结 果</b></h3>
                <h4 class="anchor-tag" id="61" name="61">2.1 两组患者cTnI水平变化的比较</h4>
                <div class="p1">
                    <p id="62">两组患者出现cTnI水平升高的患者例数不存在明显差异 (<i>P</i>&gt;0.05) 。见表1。</p>
                </div>
                <div class="area_img" id="63">
                    <p class="img_tit"><b>表</b>1 <b>两组患者心肌肌钙蛋白</b>I<b>水平比较</b> <a class="downexcel" onclick="DownLoadReportExcel(this)">导出到EXCEL</a></p>
                    <p class="img_tit"></p>
                    <p class="img_note"></p>
                    <table id="63" border="1"><tr><td><br />组别</td><td>例数</td><td>心肌肌钙蛋白I<br />升高<i>n</i> (%) </td><td>心肌肌钙蛋白I<br />不升高<i>n</i> (%) </td></tr><tr><td><br />高ANTH组</td><td>110</td><td>28 (25.45) </td><td>82 (75.55) </td></tr><tr><td><br />低ANTH组</td><td>50</td><td>13 (26.00) </td><td>37 (74.00) </td></tr><tr><td><br /><i>χ</i><sup>2</sup>/<i>P</i></td><td></td><td></td><td>0.005/0.942</td></tr></table>
                    <form name="form" action="/kxreader/Detail/DownloadReportExcel" method="POST" style="display:inline">
                        <input type="hidden" name="hidTable" value="" />
                        <input type="hidden" name="hidFileName" value="" />
                    </form>
                    <p class="img_note">注:ANTH:抗肿瘤药物累积量。下表同。</p>
                    <p class="img_note"></p>
                </div>
                <h4 class="anchor-tag" id="64" name="64">2.2 两组患者CK-MB水平变化的比较</h4>
                <div class="p1">
                    <p id="65">两组患者出现CK-MB水平升高的患者例数不存在明显差异 (<i>P</i>&gt;0.05) 。见表2。</p>
                </div>
                <div class="area_img" id="66">
                    <p class="img_tit"><b>表</b>2 <b>两组患者肌酸激酶同工酶水平比较</b> <a class="downexcel" onclick="DownLoadReportExcel(this)">导出到EXCEL</a></p>
                    <p class="img_tit"></p>
                    <p class="img_note"></p>
                    <table id="66" border="1"><tr><td><br />组别</td><td>例数</td><td>肌酸激酶同工酶<br />升高<i>n</i> (%) </td><td>肌酸激酶同工酶<br />不升高<i>n</i> (%) </td></tr><tr><td><br />高ANTH组</td><td>110</td><td>13 (11.82) </td><td>97 (88.18) </td></tr><tr><td><br />低ANTH组</td><td>50</td><td>6 (12.00) </td><td>44 (88.00) </td></tr><tr><td><br /><i>χ</i><sup>2</sup>/<i>P</i></td><td></td><td></td><td>0.001/0.974</td></tr></table>
                    <form name="form" action="/kxreader/Detail/DownloadReportExcel" method="POST" style="display:inline">
                        <input type="hidden" name="hidTable" value="" />
                        <input type="hidden" name="hidFileName" value="" />
                    </form>
                    <p class="img_note"></p>
                    <p class="img_note"></p>
                </div>
                <h4 class="anchor-tag" id="67" name="67">2.3 两组患者治疗前后BNP水平变化的比较</h4>
                <div class="p1">
                    <p id="68">治疗前, 两组患者的BNP水平无显著差异 (<i>P</i>&gt;0.05) , 治疗后, 高ANTH组的BNP水平显著高于低ANTH组 (<i>P</i>&lt;0.05) , 见表3。</p>
                </div>
                <div class="area_img" id="69">
                    <p class="img_tit"><b>表</b>3 <b>两组患者治疗前后脑钠肽水平比较</b><mathml id="70"><math xmlns="http://www.w3.org/1998/Math/MathML"><mrow><mo stretchy="false"> (</mo><mover accent="true"><mi>X</mi><mo>¯</mo></mover><mo>±</mo><mi>s</mi><mo stretchy="false">) </mo></mrow></math></mathml> <a class="downexcel" onclick="DownLoadReportExcel(this)">导出到EXCEL</a></p>
                    <p class="img_tit"></p>
                    <p class="img_note"></p>
                    <table id="69" border="1"><tr><td><br />组别</td><td>例数</td><td>治疗前<br /> (ng/L) </td><td>治疗后<br /> (ng/L) </td><td>治疗前后<br /><i>t</i>/<i>P</i></td></tr><tr><td><br />高ANTH组</td><td>110</td><td>28.2±7.5</td><td>46.9±15.2<sup>**△</sup></td><td>71.582/0.001</td></tr><tr><td><br />低ANTH组</td><td>50</td><td>28.7±8.1</td><td>41.2±15.1<sup>**</sup></td><td>-4.835/0.001</td></tr><tr><td><br /><i>t</i>/<i>P</i></td><td></td><td>0.381/0.704</td><td>2.203/0.029</td><td></td></tr></table>
                    <form name="form" action="/kxreader/Detail/DownloadReportExcel" method="POST" style="display:inline">
                        <input type="hidden" name="hidTable" value="" />
                        <input type="hidden" name="hidFileName" value="" />
                    </form>
                    <p class="img_note">注:与治疗前比较*<i>P</i>&lt;0.05, **<i>P</i>&lt;0.01;与低ANTH组比较△<i>P</i>&lt;0.05, △△<i>P</i>&lt;0.01。下表同。</p>
                    <p class="img_note"></p>
                </div>
                <h4 class="anchor-tag" id="71" name="71">2.4 两组患者治疗前后LVEF、LVFS、LVEDd、LVESd水平变化的比较</h4>
                <div class="p1">
                    <p id="72">治疗前, 两组患者的LVEF、LVFS、LVEDd、LVESd的水平无显著差异 (<i>P</i>&gt;0.05) , 治疗后, 高ANTH组LVEF显著低于低ANTH组患者 (<i>P</i>&lt;0.05) , 见表4。</p>
                </div>
                <div class="area_img" id="73">
                    <p class="img_tit"><b>表</b>4 <b>两组患者治疗前后左室射血分数等心脏指标水平比较</b><mathml id="74"><math xmlns="http://www.w3.org/1998/Math/MathML"><mrow><mo stretchy="false"> (</mo><mover accent="true"><mi>X</mi><mo>¯</mo></mover><mo>±</mo><mi>s</mi><mo stretchy="false">) </mo></mrow></math></mathml> <a class="downexcel" onclick="DownLoadReportExcel(this)">导出到EXCEL</a></p>
                    <p class="img_tit"></p>
                    <p class="img_note"></p>
                    <table id="73" border="1"><tr><td rowspan="2"><br />组别</td><td rowspan="2">例数</td><td colspan="3"><br />左室射血分数 (%) </td><td colspan="3">左室缩短率 (%) </td></tr><tr><td><br />治疗前</td><td>治疗后</td><td><i>t</i>/<i>P</i></td><td>治疗前</td><td>治疗后</td><td><i>t</i>/<i>P</i></td></tr><tr><td>高ANTH组</td><td>110</td><td>68.2±5.8</td><td>65.7±7.1<sup>**△△</sup></td><td>2.860/0.005</td><td>37.7±5.1</td><td>37.2±4.2<sup>△</sup></td><td>0.793/0.428</td></tr><tr><td><br />低ANTH组</td><td>50</td><td>68.8±5.4</td><td>71.5±5.7<sup>*</sup></td><td>2.432/0.017</td><td>37.6±5.2</td><td>38.9±4.6</td><td>1.324/0.189</td></tr><tr><td><br /><i>t</i>/<i>P</i></td><td></td><td>0.619/0.537</td><td>-3.062/0.001</td><td></td><td>0.114/0.909</td><td>-2.261/0.023</td><td></td></tr><tr><td rowspan="2"><br />组别</td><td rowspan="2">例数</td><td colspan="3"><br />左室舒张末期内径 (mm) </td><td colspan="3">左室收缩末期内径 (mm) </td></tr><tr><td><br />治疗前</td><td>治疗后</td><td><i>t</i>/<i>P</i></td><td>治疗前</td><td>治疗后</td><td><i>t</i>/<i>P</i></td></tr><tr><td>高ANTH组</td><td>110</td><td>35.3±5.1</td><td>34.6±4.6<sup>△</sup></td><td>1.069/0.286</td><td>22.6±3.1</td><td>22.7±3.4<sup>△</sup></td><td>0.228/0.820</td></tr><tr><td><br />低ANTH组</td><td>50</td><td>36.7±4.9</td><td>32.8±4.3<sup>**</sup></td><td>4.230/0.001</td><td>22.8±2.9</td><td>21.4±2.6<sup>*</sup></td><td>2.542/0.013</td></tr><tr><td><br /><i>t</i>/<i>P</i></td><td></td><td>1.629/0.105</td><td>2.438/0.021</td><td></td><td>0.386/0.700</td><td>2.533/0.013</td><td></td></tr></table>
                    <form name="form" action="/kxreader/Detail/DownloadReportExcel" method="POST" style="display:inline">
                        <input type="hidden" name="hidTable" value="" />
                        <input type="hidden" name="hidFileName" value="" />
                    </form>
                    <p class="img_note"></p>
                    <p class="img_note"></p>
                </div>
                <h4 class="anchor-tag" id="75" name="75">2.5 高ANTH组患者BNP水平变化与LVEF、LVFS的相关性分析</h4>
                <div class="p1">
                    <p id="76">以治疗前后LVEF、LVFS变化的差值为横轴, 以治疗前后BNP变化的差值为纵轴, 通过直线相关散点图1可知, 治疗前后BNP与LVEF、LVFS的变化不存在明显相关性 (<i>r</i><sub>LVEF</sub>=-0.30, <i>P</i><sub>LVEF</sub>=0.659;<i>r</i><sub>LVFS</sub>=0.002, <i>P</i><sub>LVFS</sub>=0.973) 。</p>
                </div>
                <div class="area_img" id="77">
                                <a class="zoom-in" href="Detail/GetImg?filename=images/XXGK201902020_077.jpg&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                    <img alt="图1 高ANTH组患者BNP水平变化与LVEF、LVFS的相关性分析" src="Detail/GetImg?filename=images/XXGK201902020_077.jpg&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" />
                                </a>
                                <p class="img_tit"><b>图</b>1 <b>高</b>ANTH<b>组患者</b>BNP<b>水平变化与</b>LVEF、LVFS<b>的相关性分析</b>  <a class="btn-zoomin" href="Detail/GetImg?filename=images/XXGK201902020_077.jpg&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!"></a><a class="downimg">&nbsp;&nbsp;下载原图</a></p>
                            <p class="img_tit"></p>

                </div>
                <h3 id="78" name="78" class="anchor-tag"><b>3 讨 论</b></h3>
                <div class="p1">
                    <p id="79">蒽环类抗肿瘤药物在临床的抗癌治疗中应用广泛, 但其仍会导致患者出现心脏损害、骨髓抑制、脱发等不良事件, 其中以心脏毒性最为严重, 这使得蒽环类抗肿瘤药物的使用范围大大被限制<citation id="152" type="reference"><link href="120" rel="bibliography" /><sup>[<a class="sup">9</a>]</sup></citation>。现阶段, 对于蒽环类抗肿瘤药物对于心脏毒性的影响, 采取的主要措施为早发现、早诊断、早治疗。近年来, 检测患者的肌钙蛋白I、心肌酶谱、脑钠肽等水平的变化, 是对蒽环类抗肿瘤药物对患者心脏损害的主要监测方法<citation id="153" type="reference"><link href="122" rel="bibliography" /><sup>[<a class="sup">10</a>]</sup></citation>。按照蒽环类抗肿瘤药物导致心脏损害发生的时间不同, 可以分为以下三种类型:慢性、急性、迟发性心脏毒性。其中慢性心脏毒性是一种较为常见的类型, 会在停药1年内出现心肌病、心功能下降、心律失常、心力衰竭等症状, 起病时不易察觉, 但其发展不可逆转<citation id="154" type="reference"><link href="124" rel="bibliography" /><sup>[<a class="sup">11</a>]</sup></citation>。相关资料表明, 蒽环类抗肿瘤药物累积量与慢性心脏毒性呈正相关关系, ANTH也是引起慢性心脏毒性的最主要原因<citation id="155" type="reference"><link href="126" rel="bibliography" /><sup>[<a class="sup">12</a>]</sup></citation>。而急性心脏毒性的发生率较小, 主要是指在用药期短时间内出现心包-心肌炎综合征、心力衰竭、心律失常等, 大多数患者的症状能在停药后自行缓解, 和药物剂量及用药方案不存在明显的相关性<citation id="156" type="reference"><link href="128" rel="bibliography" /><sup>[<a class="sup">13</a>]</sup></citation>。一般情况下, ANTH≥300mg/m<sup>2</sup>时会引起患者心室结构发生变化, 增加心力衰竭的发生率。但是一些研究在对ANTH&lt;100mg/m<sup>2</sup>的患者进行随访中, 也发现了左心室结构和功能的改变。另外, 本文研究对象蒽环类抗肿瘤药物用量基本在60～160mg/m<sup>2</sup>之间的, 所以本文研究以ANTH=100mg/m<sup>2</sup>作为分界点, 将患者分为高ANTH组和低ANTH组, 以此对蒽环类抗肿瘤药物对患者心脏毒性的影响进行研究<citation id="157" type="reference"><link href="130" rel="bibliography" /><sup>[<a class="sup">14</a>]</sup></citation>。</p>
                </div>
                <div class="p1">
                    <p id="80">本研究结果表明, 两组患者出现CK-MB水平升高的患者例数不存在明显差异 (<i>P</i>&gt;0.05) , 而国外一研究表明, 在使用小鼠模型进行研究的过程中, 应用大量大霉素后, 小鼠CK-MB水平显著升高。推测出现此差异的原因主要是, 本文研究中ANTH基本控制在相对安全的范围内。在心肌由于缺氧或缺血等因素出现病变及坏死的情况时, 肌钙蛋白I会释放并进入血液。现阶段, 对于蒽环类抗肿瘤药物导致心脏毒性的病理机制尚未明确, 但已有大量研究表明, 这类药物能够通过各种途径, 使患者的心肌细胞出现不同程度的坏死、凋亡或自噬<citation id="158" type="reference"><link href="132" rel="bibliography" /><sup>[<a class="sup">15</a>]</sup></citation>。在此过程中, 会导致肌钙蛋白I的释放, 肌钙蛋白I的水平在一定程度上能够反映出患者心脏损伤的程度<citation id="159" type="reference"><link href="134" rel="bibliography" /><sup>[<a class="sup">16</a>]</sup></citation>。而本文研究结果显示, 两组患者出现肌钙蛋白I水平升高的患者例数不存在明显差异 (<i>P</i>&gt;0.05) , 表明肌钙蛋白I的升高现象与患者ANTH不存在明显的相关性。推测患者在使用较低剂量的蒽环类抗肿瘤药物的情况下就出现心脏损伤, 其原因是患者与该药物代谢相关的基因存在一定差异, 使得不同患者对此类药物的易感性也存在差异。</p>
                </div>
                <div class="p1">
                    <p id="81">BNP是一名日本学者在猪脑中首次发现的, 是由心室肌细胞分泌产生的一种多肽类激素, 由多种氨基酸组成, 能够起到稳定血容量和反映心室功能的作用。BNP是利钠肽系统的一个组成部分, 能够起到利钠、利尿及扩张血管的作用, 如果机体出现容量压力负荷增加或心室扩张的现象, 其水平会随之增加<citation id="160" type="reference"><link href="136" rel="bibliography" /><sup>[<a class="sup">17</a>]</sup></citation>。通过对本文研究结果的分析可发现, BNP与肌钙蛋白I和肌氨酸酐致活酶的水平不存在明显的相关性。分析其原因为, 心室负荷的增加会使患者BNP分泌增加, 导致其BNP浓度上升, cTnI和CK-MB水平的升高主要是由于心肌细胞受到破坏而引起的。另外, 本文研究结果显示, 治疗前, 两组患者的脑钠肽 (BNP) 水平不存在显著差异 (<i>P</i>&gt;0.05) , 治疗完成后, 高ANTH组患者的BNP水平显著高于低ANTH组患者 (<i>P</i>&lt;0.05) 。这说明ANTH越高, 患者BNP水平越高, 蒽环类抗肿瘤药物对患者心室负荷产生了较大的影响。</p>
                </div>
                <div class="p1">
                    <p id="82">另外, 需要注意的是, 对于蒽环类抗肿瘤药物对患者产生的心脏毒性进行防治的措施主要有以下几点:第一, 对使用蒽环类药物进行抗肿瘤治疗的患者进行相应的监测, 包括治疗前、治疗过程中及治疗结束后三个时间段患者心脏的基本情况;第二, 限制蒽环类抗肿瘤药物的累积用量, 最高累积用量为表柔比星900mg/m<sup>2</sup>、多柔比星450mg/m<sup>2</sup>、去甲柔红霉素900mg/m<sup>2</sup>、柔红霉素900mg/m<sup>2</sup><citation id="161" type="reference"><link href="138" rel="bibliography" /><sup>[<a class="sup">18</a>]</sup></citation>;第三, 使用脂质体蒽环类药物替代蒽环类药物, 脂质体蒽环类药物不仅能够提高患者治疗疗效, 还能够减少相应毒副作用的出现, 提高治疗的安全性和有效性;第四, 药物干预, 以右丙亚胺为典型代表的铁离子螯合剂能够降低心脏事件发生的可能性, 如果治疗过程中患者的ANTH超过了300mg/m<sup>2</sup>, 则应考虑右丙亚胺的使用<citation id="162" type="reference"><link href="140" rel="bibliography" /><sup>[<a class="sup">19</a>]</sup></citation>;第五, 抗氧化剂, 黄酮类化合物和降脂药物均具有一定的抗氧化作用, 能够预防或减少蒽环类抗肿瘤药物引起的心脏损伤, 同时对其治疗效果不会产生较大影响<citation id="163" type="reference"><link href="142" rel="bibliography" /><sup>[<a class="sup">20</a>]</sup></citation>。</p>
                </div>
                <div class="p1">
                    <p id="83">综上所述, 蒽环类抗肿瘤药物会使患者的BNP水平显著升高, LVEF水平显著下降, 引起患者心脏毒性的产生或发展, 因此, 应采取一定的防治措施减少其对患者心脏产生的不良影响。</p>
                </div>

        <!--brief end-->
        
        <!--conten left  end-->
        <!--增强附件-->
        

        <!--reference start-->
            <div class="reference anchor-tag" id="a_bibliography">
                    <h3>参考文献</h3>
                                        <p id="104">
                            <a id="bibliography_1" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=HNGY201501033&amp;v=MDg2MTlHRnJDVVI3cWZadVptRnlqbVY3dk9MU1BNZDdHNEg5VE1ybzlHWjRRS0RIODR2UjRUNmo1NE8zenFxQnQ=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[1]</b>杜天幸, 杨继元.蒽环类抗肿瘤药物对心脏毒性防治的研究进展[J].华南国防医学杂志, 2015, 29 (1) :80-82.
                            </a>
                        </p>
                        <p id="106">
                            <a id="bibliography_2" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=YXZS201508044&amp;v=MDkwMjlqNTRPM3pxcUJ0R0ZyQ1VSN3FmWnVabUZ5am1WN3ZPUERYUmZiRzRIOVRNcDQ5QllJUUtESDg0dlI0VDY=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[2]</b>吴周贵, 李金国.超声心动图对蒽环类化疗药物心脏毒性的评价进展[J].医学综述, 2015, 21 (8) :1452-1454.
                            </a>
                        </p>
                        <p id="108">
                            <a id="bibliography_3" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=ZLQG201701018&amp;v=MDM5MzJPM3pxcUJ0R0ZyQ1VSN3FmWnVabUZ5am1WN3ZPUHlIYWFiRzRIOWJNcm85RWJJUUtESDg0dlI0VDZqNTQ=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[3]</b>林莹, 李彦华, 郭新红, 等.蒽环类抗肿瘤药诱发心肌病1例及文献复习[J].中华老年多器官疾病杂志, 2017, 16 (1) :61-63.
                            </a>
                        </p>
                        <p id="110">
                            <a id="bibliography_4" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=ZGYX201612001&amp;v=MjIyMzE0TzN6cXFCdEdGckNVUjdxZlp1Wm1GeWptVjd2T1B5clNkckc0SDlmTnJZOUZaWVFLREg4NHZSNFQ2ajU=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[4]</b>赵越, 李怀业, 袁兰, 等.蒽环类化合物的结构修饰及抗肿瘤活性研究进展[J].中国药学杂志, 2016, 51 (12) :953-961.
                            </a>
                        </p>
                        <p id="112">
                            <a id="bibliography_5" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=ZXDY201712021&amp;v=MDA0NjRSN3FmWnVabUZ5am1WN3ZPUHpYUGQ3RzRIOWJOclk5SFpZUUtESDg0dlI0VDZqNTRPM3pxcUJ0R0ZyQ1U=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[5]</b>王琳, 杨雪, 肖玲芳, 等.蒽环类药物心脏毒性分析及临床使用建议[J].中国现代医学杂志, 2017, 27 (12) :101-105.
                            </a>
                        </p>
                        <p id="114">
                            <a id="bibliography_6" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=GEKX201601003&amp;v=MjAxMTQ5Rlo0UUtESDg0dlI0VDZqNTRPM3pxcUJ0R0ZyQ1VSN3FmWnVabUZ5am1WN3ZPSWlqQWRyRzRIOWZNcm8=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[6]</b>胡慧敏, 张伟令, 黄东生, 等.儿童蒽环类药物心脏毒性研究进展[J].国际儿科学杂志, 2016, 43 (1) :1-4.
                            </a>
                        </p>
                        <p id="116">
                            <a id="bibliography_7" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=LCYX201601033&amp;v=MTg4MDdUNmo1NE8zenFxQnRHRnJDVVI3cWZadVptRnlqbVY3dk9LUzdTZHJHNEg5Zk1ybzlHWjRRS0RIODR2UjQ=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[7]</b>张楚婕, 程蕾蕾.蒽环类药物致心脏毒性的预防与治疗现状[J].中国临床医学, 2016, 23 (1) :110-113.
                            </a>
                        </p>
                        <p id="118">
                            <a id="bibliography_8" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=YXZS201606032&amp;v=MDU4MjBQRFhSZmJHNEg5Zk1xWTlHWm9RS0RIODR2UjRUNmo1NE8zenFxQnRHRnJDVVI3cWZadVptRnlqbVY3dk8=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[8]</b>慕万颖, 刘伶.蒽环类药物治疗儿童白血病致心脏损害的评价及对策[J].医学综述, 2016, 22 (6) :1145-1148.
                            </a>
                        </p>
                        <p id="120">
                            <a id="bibliography_9" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=NMYX201603016&amp;v=MDQyOTE0TzN6cXFCdEdGckNVUjdxZlp1Wm1GeWptVjd2T0t5RFNkckc0SDlmTXJJOUVZb1FLREg4NHZSNFQ2ajU=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[9]</b>金之湲, 胡燕华.超声心动图评估蒽环类化疗药物心脏毒性的临床研究进展[J].内蒙古医科大学学报, 2016, 38 (3) :255-258.
                            </a>
                        </p>
                        <p id="122">
                            <a id="bibliography_10" target="_blank" href="http://scholar.cnki.net/result.aspx?q=Current views on anthracycline cardiotoxicity">

                                <b>[10]</b>Mele D, Nardozza M, Spallarossa P, et al.Current views on anthracycline cardiotoxicity[J].Heart Fail Rev, 2016, 21 (5) :621-634.
                            </a>
                        </p>
                        <p id="124">
                            <a id="bibliography_11" target="_blank" href="/kcms/detail/detail.aspx?dbcode=SJWK&amp;filename=SJWK15060400000041&amp;v=MjcxNjNQUUgvaXJSZEdlcnFRVE1ud1plWnRGaW5sVXJmSUlGMFFiaFE9TmlmY1piSzlIdGZNcTQ5RlpPc1BESGc0b0JNVDZUNA==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[11]</b>Cardinale D, Colombo A, Bacchiani G, et al.Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy[J].Circulation, 2015, 131 (22) :1981-1988.
                            </a>
                        </p>
                        <p id="126">
                            <a id="bibliography_12" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=NKJW201701023&amp;v=MDAyNTQ5SFo0UUtESDg0dlI0VDZqNTRPM3pxcUJ0R0ZyQ1VSN3FmWnVabUZ5am1WN3ZPS3liQmViRzRIOWJNcm8=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[12]</b>罗霞, 程黎明.抗癌药物引起心脏毒性的生物标志物研究进展[J].内科急危重症杂志, 2017, 23 (1) :65-69.
                            </a>
                        </p>
                        <p id="128">
                            <a id="bibliography_13" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=YWLC201611039&amp;v=MTAyNDRSN3FmWnVabUZ5am1WN3ZPUERySGJiRzRIOWZOcm85R2JZUUtESDg0dlI0VDZqNTRPM3pxcUJ0R0ZyQ1U=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[13]</b>姚亮, 张晓娟, 田富国.小剂量卡维地洛联合坎地沙坦与右丙亚胺对接受蒽环类药物化疗乳腺癌患者的心脏保护作用的对比研究[J].中国药物与临床, 2016, 16 (11) :1634-1637.
                            </a>
                        </p>
                        <p id="130">
                            <a id="bibliography_14" target="_blank" href="/kcms/detail/detail.aspx?dbcode=SJES&amp;filename=SJES15122500348534&amp;v=MTI5NDI4OW9CTVQ2VDRQUUgvaXJSZEdlcnFRVE1ud1plWnRGaW5sVXJmSUlGMFFiaFE9TmlmT2ZiSzlIOVBPcW85RlorOEhDWA==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[14]</b>Adamcova M, Lencova Popelova O, Jirkovsky E, et al.Experimental determination of diagnostic window of cardiac troponins in the development of chronic anthracycline cardiotoxicity and estimation of its predictive value[J].Int J Cardiol, 2015, 201 (2) :358-367.
                            </a>
                        </p>
                        <p id="132">
                            <a id="bibliography_15" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=HAIN201524022&amp;v=MDMwODFIODR2UjRUNmo1NE8zenFxQnRHRnJDVVI3cWZadVptRnlqbVY3dk9MU3pDWUxHNEg5VE9xNDlIWm9RS0Q=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[15]</b>覃业语, 苏素文.抗肿瘤药物心脏毒性作用机制研究进展[J].海南医学, 2015, 26 (24) :3661-3664.
                            </a>
                        </p>
                        <p id="134">
                            <a id="bibliography_16" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=XXGB201605016&amp;v=Mjc3Nzc3dk9QVFhNYkxHNEg5Zk1xbzlFWW9RS0RIODR2UjRUNmo1NE8zenFxQnRHRnJDVVI3cWZadVptRnlqbVY=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[16]</b>汪羚利, 陈少敏, 李昭屏.超声心动图评价抗肿瘤药物心脏毒性的研究进展[J].心血管病学进展, 2016, 37 (5) :516-521.
                            </a>
                        </p>
                        <p id="136">
                            <a id="bibliography_17" target="_blank" href="http://scholar.cnki.net/result.aspx?q=Synthesis and analysis of novel analogues of dexrazoxane and its open-ring hydrolysis product for protection against anthracycline cardiotoxicity in vitro and in vivo">

                                <b>[17]</b>Jirkovská-Vávrová A, Roh á O, et al.Synthesis and analysis of novel analogues of dexrazoxane and its open-ring hydrolysis product for protection against anthracycline cardiotoxicity in vitro and in vivo[J].Toxicol Res, 2015, 4 (4) :1098-1114.
                            </a>
                        </p>
                        <p id="138">
                            <a id="bibliography_18" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=XXGK201603031&amp;v=MTUzMTZaWVFLREg4NHZSNFQ2ajU0TzN6cXFCdEdGckNVUjdxZlp1Wm1GeWptVjd2T1BUWE1aYkc0SDlmTXJJOUc=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[18]</b>卢少玲, 张烁.病毒性心肌炎演变为扩张型心肌病的机制[J].心血管康复医学杂志, 2016, 25 (3) :341-343.
                            </a>
                        </p>
                        <p id="140">
                            <a id="bibliography_19" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=XXGK201602035&amp;v=MDU0NjViRzRIOWZNclk5R1lZUUtESDg0dlI0VDZqNTRPM3pxcUJ0R0ZyQ1VSN3FmWnVabUZ5am1WN3ZPUFRYTVo=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[19]</b>吴红, 韩薇.mTOR信号通路在心血管系统中作用研究的进展[J].心血管康复医学杂志, 2016, 25 (2) :225-228.
                            </a>
                        </p>
                        <p id="142">
                            <a id="bibliography_20" target="_blank" href="http://scholar.cnki.net/result.aspx?q=Characterisation of anthracycline cardiotoxicity in long-term childhood cancer survivors using conventional and novel CMR techniques:probing the pathology">

                                <b>[20]</b>Quyam S, Steeden J, Muthurangu V, et al.Characterisation of anthracycline cardiotoxicity in long-term childhood cancer survivors using conventional and novel CMR techniques:probing the pathology[J].J Cardiovasc Magn Reson, 2015, 17 (1) :1-3.
                            </a>
                        </p>
            </div>
        <!--reference end-->
        <!--footnote start-->
        <!--footnote end-->



    </div>

        <input id="fileid" type="hidden" value="XXGK201902020" />
        <input id="dpi" type="hidden" value="600" />
    </div>

<script>
var _hmt = _hmt || [];
(function() {
  var hm = document.createElement("script");
  hm.src = "https://hm.baidu.com/hm.js?6e967eb120601ea41b9d312166416aa6";
  var s = document.getElementsByTagName("script")[0];
  s.parentNode.insertBefore(hm, s);
})();
</script>

    


<input id="hid_uid" name="hid_uid" type="hidden" value="WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" />
<input id="hid_kLogin_headerUrl" name="hid_kLogin_headerUrl" type="hidden" value="/KLogin/Request/GetKHeader.ashx%3Fcallback%3D%3F" />
<input id="hid_kLogin_footerUrl" name="hid_kLogin_footerUrl" type="hidden" value="/KLogin/Request/GetKFooter.ashx%3Fcallback%3D%3F" />
<div class="btn-link" style="display: none"><a target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=XXGK201902020&amp;v=MTExMDhIOWpNclk5SFpJUUtESDg0dlI0VDZqNTRPM3pxcUJ0R0ZyQ1VSN3FmWnVabUZ5am1WN3ZPUFRYTVpiRzQ=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">知网节</a></div>
<div class="popflow" id="popupTips" style="display: none;">
    <div class="popflowArr"></div>
    <div class="popflowCot">
        <div class="hd"><a href="javascript:void(0);" onclick="$('#popupTips').hide();$('#popupmsg').html('')" class="close">X</a></div>
        <div class="bd">
            <p class="mes" id="popupmsg" name="popupmsg"></p>
          
        </div>
    </div>
</div>
<input type="hidden" id="myexport" value="//kns.cnki.net" />

<input type="hidden" id="KPCAPIPATH" value="//ishufang.cnki.net" />
<input type="hidden" id="CitedTimes" value="1" />
<div class="link" id="GLSearch" style="display: none;">
    <i class="icon-trangle"></i>
    <div class="inner">
        <a class="icon" id="copytext">复制</a>
        <a class="icon" target="_blank" onclick="searchCRFD(this)">工具书搜索</a>
    </div>
</div>




<input id="hidVirtualPath" name="hidVirtualPath" type="hidden" value="/kxreader" />
<script src="/kxreader/bundles/detail?v=842_VlRz_g1CMCLi-M0twVw-4EOFG_noWyi_OsMnrAg1"></script>

<script src="/kxreader/Scripts/layer.min.js" type="text/javascript"></script>

<div id="footerBox" class="rootw footer">
</div>
<script>
    if (typeof FlushLogin == 'function') {
        FlushLogin();
    }
    modifyEcpHeader(true);
</script>

<!--图片放大功能 start-->
<script src="/kxreader/bundles/imagebox?v=W4phPu9SNkGcuPeJclikuVE3PpRyIW_gnfjm_19nynI1"></script>

<script type="text/javascript">
    $(function () {
        var j = $.noConflict();
        j(function () {
            j(".zoom-in,.btn-zoomin").imgbox({
                'alignment': 'center',
                'allowMultiple': false,
                'overlayShow': true
            });
        })
    });
</script>
<!--图片放大功能 end-->
<div class="fixedbar">
    <div class="backtop hiddenV" id="backtop">
        <a id="backTopSide" href="javascript:scroll(0,0);" title=""></a>
    </div>
</div>
<script type="text/javascript" src="/kxreader/Scripts/MathJax-2.6-latest/MathJax.js?config=MML_HTMLorMML-full"></script>

</body>
</html>
